Related Experiment Video

Updated: May 12, 2026

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions
08:17

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

Published on: October 30, 2016

The current status and future impact of targeted therapies in non-Hodgkin lymphoma

Chaitra Ujjani1, Bruce D Cheson

  • 1Georgetown University, 3800 Reservoir Rd. NW, Washington, DC 20007, USA. csu@georgetown.edu

Expert Review of Hematology
|April 4, 2013
PubMed

Insights

New targeted therapies, including advanced monoclonal antibodies and kinase inhibitors, offer improved specificity and safety for treating lymphoid malignancies compared to traditional chemotherapy.

Area of Science:

  • Oncology
  • Immunology
  • Pharmacology

Background:

  • Biologic targeted therapies represent a significant advancement in treating lymphoid malignancies.
  • Existing treatments like rituximab have paved the way for newer agents with improved characteristics.

Purpose of the Study:

  • To review novel biologic targeted therapies for lymphoid malignancies.
  • To highlight advancements in monoclonal antibodies and small-molecule kinase inhibitors.
  • To discuss agents targeting the tumor microenvironment.

Main Methods:

  • Review of emerging targeted therapies for lymphoid cancers.
  • Analysis of novel monoclonal antibodies targeting extracellular antigens (e.g., CD20).
  • Examination of small-molecule kinase inhibitors targeting intracellular pathways.

Main Results:

  • New anti-CD20 monoclonal antibodies exhibit enhanced binding and varied mechanisms.
  • Antibodies are being conjugated with radioisotopes and toxins for targeted delivery.
  • Small-molecule kinase inhibitors show promise in targeting disease pathogenesis.
  • Therapies modulating the tumor microenvironment are under investigation.

Conclusions:

  • Targeted agents offer greater tumor specificity and a better toxicity profile than standard chemotherapy.
  • These novel therapies hold potential for improved long-term outcomes in lymphoid malignancies.
  • Further research and appropriate clinical settings are crucial for optimizing their use.

More Related Videos

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells11:08

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...